Cheap drugs will become a luxury for Russians

the Lack of support of producers on the state level and the impact on the economy caused by the pandemic, it seems, speeds up the elimination of several vital drugs off the market. Russian farm frightened the already close to fainting consumers that will soon cease production of the five dozen drugs from cheep vital and necessary (EDL) to produce them became absolutely unprofitable, substance has increased dramatically in price, and the need for compliance with the state regulation of prices forced to go to extreme steps.

Recall all drugs from the essential drugs list must be sold at prices regulated by the state, some of which are almost impossible to change for the past ten years. Since the summer of last year, when about the pandemic, no one thought, the country began to unfold medicines disaster medicine, both foreign and Russian began to leave the Russian market. The very idea of state regulation of prices showed its complete failure. Russian companies have the right to index the price only once a year for inflation, but not more than 6%, foreign – less.

In the end, it was reported that last year was not held every third tender for public procurement – applications from the manufacturers just received. First and foremost, the situation has touched drugs for the treatment of cancer, some cough medicine, Allergy, cardiovascular diseases. In total, I left the market around 1000 (!) medicinal items. Recently, the media reported that not hosted a regular gostender – purchase of drugs against HIV infection.

Meanwhile, during a pandemic, the outflow of medicines from pharmacies continued. So, today in the afternoon with fire not to find a synthetic hormone for the treatment of diseases of the thyroid gland by some means from the blood pressure. No CREON and vigantol. The wave of panic people bought antipyretic and antiviral, it is still nowhere paracetamol. “Familiar with a confirmed diagnosis kovid prescribed drug Kaletra – it is not anywhere”, – says a resident of Ephraim Sergei Churilov.

still no drugs for seriously ill patients with cystic fibrosis, most of whom are children. In social networks people reported that missing a drugs tiopc and azathioprine, inhaled colistin, Liprimar… a Victim of the pandemic were people with severe rheumatic diseases: pharmacy has gone serious drug plaquenil for such patients, who in the world is explored (so far with very mixed success and ground side) from the crown.

But our troubles did not end there. Several Russian pharmaceutical companies has notified the Ministry that are soon going to cease production of drugs cheap segmentand. In the list of “out” came in and without missing paracetamol, glucose, ibuprofen, diphenhydramine. For example, paracetamol our company must give the state at 10.1 per ruble-but the cost of cost of 16.46 ruble; ibuprofen should be sold more expensive 12.05 ruble, and the production costs 17.21 ruble. Substance (its production of the substances in Russia) in connection with the change in the exchange rate has risen. And, for example, a kilogram of the substance for ibuprofen is now 22 and $ 28. Some production left to operate at a loss.

Recently, the government decided to make some concessions during the registration of prices for drugs from the essential drugs, allowing to re-register them until the end of 2020. The cost of innovative drugs shall not exceed prices overseas, and the price of analogs will be used to reduce the ratio. Also, prices cannot exceed the existing ones. Maybe these rules will change, but to correct the situation is unlikely. So, foreign manufacturers took a decision to withdraw from the market, after weighing all the pros and cons and if they agree to return, it will take at least two years. But until they agree, and the situation with some vital drugs is solved only in manual mode. “Today the only possible solution: to give the manufacturer the right to petition for change by providing objective evidence of change. One of the last decisions of the Government of the Russian Federation No. 441 allows to raise the price of the medicine (if medicine disappeared because of the price), but we must inform you that there are difficulties with accessibility. Other ways yet,” – said the head of the Russian League of Patients Alexander Saversky.

…it’s Funny that only on 16 April, the Association of Russian pharmaceutical manufacturers issued an official statement that shortages of drugs and not going. “We have sufficient stocks of medicines and raw materials, created all the necessary reserves,” – said the head of the Association of Victor Dmitriev. He assured that all drugs for symptomatic treatment, antipyretics, antiviral is available. And some of our producers have started the delivery of interferons in the countries of South-East Asia.